The agency could be in a position to act very quickly, depending on what the outcome of that meeting is.Former FDA Commissioner Scott Gottlieb on booster or third-dose COVID-19 vaccines.
- An advisory panel will meet on Friday to discuss specifically Pfizer’s application for a third or “booster” dose of the vaccine.
- Dr. Gottlieb (also on the board of Pfizer) says he believes the boosters will likely be prioritized for those older and more at risk for severe implications from COVID-19.
Why It Matters: Questions about vaccine efficacy remain as the United States nears a year since the first dose was administered to the public but infections continue to rise nationwide.
Link to Dr. Gottlieb’s interview: CLICK HERE
by Jenna Lee,